The results of the adjuvant chemotherapy of patients with small-cell lung cancer

The effectiveness of treatment (surgery; surgery + chemotherapy) was compared in a group of 122 patients with small-cell lung cancer. Median survival after postoperative chemotherapy rose from 40.9 to 81.8 weeks. However, five-year survival was nearly identical--8.1% (surgery) and 10.0% (surgery + c...

Full description

Saved in:
Bibliographic Details
Published inVoprosy onkologij Vol. 35; no. 2; p. 172
Main Authors Grants, E A, Berzinia, V Iu, Bashko, Ia Ia, Zitare, I Ia, Berzin'sh, Iu A
Format Journal Article
LanguageRussian
Published Russia (Federation) 1989
Subjects
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Carcinoma, Small Cell - drug therapy
Carcinoma, Small Cell - mortality
Combined Modality Therapy
Evaluation Studies as Topic
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - mortality
Pneumonectomy
Postoperative Care
Online AccessGet more information

Cover

More Information
Summary:The effectiveness of treatment (surgery; surgery + chemotherapy) was compared in a group of 122 patients with small-cell lung cancer. Median survival after postoperative chemotherapy rose from 40.9 to 81.8 weeks. However, five-year survival was nearly identical--8.1% (surgery) and 10.0% (surgery + chemotherapy).
ISSN:0507-3758